Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tangsheng Yi

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Elife|May 18, 2013
EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen captureTangsheng Yi, Jason G Cyster
Current Opinion in Immunology|May 1, 2021
Mast cell tryptases in allergic inflammation and immediate hypersensitivityJonathan J Lyons, Tangsheng Yi
The Journal of Experimental Medicine|October 1, 2020
The role of IL-22 in intestinal health and diseaseMary Keir, Tangsheng Yi, Timothy Lu, et al.
Nature|May 6, 2016
EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cellsJianhua Li, Erick Lu, Tangsheng Yi, et al.
Nature Reviews. Immunology|October 18, 2014
25-Hydroxycholesterols in innate and adaptive immunityJason G Cyster, Eric V Dang, Andrea Reboldi, et al.
Cancer Research|December 17, 2010
IL-17 enhances tumor development in carcinogen-induced skin cancerLin Wang, Tangsheng Yi, Wang Zhang, et al.
The Journal of Experimental Medicine|July 1, 2009
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathwayLin Wang, Tangsheng Yi, Marcin Kortylewski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2011
EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissuesLisa M Kelly, João P Pereira, Tangsheng Yi, et al.
Cancer Research|February 7, 2007
Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptorFan Yang, Xiongfei Huang, Tangsheng Yi, et al.
FEBS Letters|July 19, 2005
Regulation of lipopolysaccharide-induced inflammatory response by glutathione S-transferase P1 in RAW264.7 cellsBin Xue, Yifan Wu, Zhimin Yin, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Elife|May 18, 2013
EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen captureTangsheng Yi, Jason G Cyster
Current Opinion in Immunology|May 1, 2021
Mast cell tryptases in allergic inflammation and immediate hypersensitivityJonathan J Lyons, Tangsheng Yi
The Journal of Experimental Medicine|October 1, 2020
The role of IL-22 in intestinal health and diseaseMary Keir, Tangsheng Yi, Timothy Lu, et al.
Nature|May 6, 2016
EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cellsJianhua Li, Erick Lu, Tangsheng Yi, et al.
Nature Reviews. Immunology|October 18, 2014
25-Hydroxycholesterols in innate and adaptive immunityJason G Cyster, Eric V Dang, Andrea Reboldi, et al.
Cancer Research|December 17, 2010
IL-17 enhances tumor development in carcinogen-induced skin cancerLin Wang, Tangsheng Yi, Wang Zhang, et al.
The Journal of Experimental Medicine|July 1, 2009
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathwayLin Wang, Tangsheng Yi, Marcin Kortylewski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2011
EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissuesLisa M Kelly, João P Pereira, Tangsheng Yi, et al.
Cancer Research|February 7, 2007
Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptorFan Yang, Xiongfei Huang, Tangsheng Yi, et al.
FEBS Letters|July 19, 2005
Regulation of lipopolysaccharide-induced inflammatory response by glutathione S-transferase P1 in RAW264.7 cellsBin Xue, Yifan Wu, Zhimin Yin, et al.
Pageof 4